Estradiol and isotype-selective estrogen receptor agonists modulate the mesocortical dopaminergic system in gonadectomized female rats

• Published in: Brain research 2014-10, Vol.1583, p.1-11
• Main Authors: Sárvári, Miklós, Deli, Levente, Kocsis, Pál, Márk, László, Maász, Gábor, Hrabovszky, Erik, Kalló, Imre, Gajári, Dávid, Vastagh, Csaba, Sümegi, Balázs, Tihanyi, Károly, Liposits, Zsolt
• Format: Article
• Language: English
• Subjects: 3,4-Dihydroxyphenylacetic Acid - metabolism; Animals; Biological and medical sciences; Cerebrovascular Circulation - drug effects; Cerebrovascular Circulation - physiology; Dextroamphetamine - pharmacology; Dopamine; Dopamine - metabolism; Dopamine Plasma Membrane Transport Proteins - metabolism; Dopamine Uptake Inhibitors - pharmacology; Estradiol; Estradiol - pharmacology; Estrogen receptor alpha; Estrogen Receptor alpha - agonists; Estrogen Receptor alpha - metabolism; Estrogen receptor beta; Estrogen Receptor beta - agonists; Estrogen Receptor beta - metabolism; Estrogens - pharmacology; Female; Fundamental and applied biological sciences. Psychology; Lactones - pharmacology; Mesocortical pathway; Neurology; Nitriles - pharmacology; Ovariectomy; Oxygen - blood; Prefrontal Cortex - drug effects; Prefrontal Cortex - physiology; Propionates - pharmacology; Rat; Rats, Wistar; Receptors, Dopamine - metabolism; Ventral Tegmental Area - drug effects; Ventral Tegmental Area - physiology; Vertebrates: nervous system and sense organs
• ISSN: 0006-8993; 1872-6240
• DOI: 10.1016/j.brainres.2014.06.020

Abstract The mesocortical dopaminergic pathway projecting from the ventral tegmental area (VTA) to the prefrontal cortex (PFC) contributes to the processing of reward signals. This pathway is regulated by gonadal steroids including estradiol. To address the putative role of estradiol and isotype-selective estrogen receptor (ER) agonists in the regulation of the rodent mesocortical system, we combined fMRI, HPLC–MS and qRT-PCR techniques. In fMRI experiments adult, chronically ovariectomized rats, treated with either vehicle, estradiol, ERα agonist 16α-lactone-estradiol (LE2) or ERβ agonist diarylpropionitrile (DPN), received a single dose of d -amphetamine-sulphate (10 mg/kg, i.p.) and BOLD responses were monitored in the VTA and the PFC. Ovariectomized rats showed no significant response to amphetamine. In contrast, the VTA of ER agonist-substituted ovariectomized rats showed robust amphetamine-evoked BOLD increases. The PFC of estradiol-replaced animals was also responsive to amphetamine. Mass spectroscopic analysis of dopamine and its metabolites revealed a two-fold increase in both dopamine and 3,4-dihydroxyphenylacetic acid content of the PFC in estradiol-replaced animals compared to ovariectomized controls. qRT-PCR studies revealed upregulation of dopamine transporter and dopamine receptor in the VTA and PFC, respectively, of ER agonist-treated ovariectomized animals. Collectively, the results indicate that E2 and isotype-selective ER agonists can powerfully modulate the responsiveness of the mesocortical dopaminergic system, increase the expression of key genes related to dopaminergic neurotransmission and augment the dopamine content of the PFC. In a broader sense, the findings support the concept that the manifestation of reward signals in the PFC is dependent on the actual estrogen milieu of the brain.